MASERA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 7.247
AS - Asia 3.242
EU - Europa 2.593
SA - Sud America 435
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 64
OC - Oceania 6
Totale 13.667
Nazione #
US - Stati Uniti d'America 6.874
SG - Singapore 1.127
CN - Cina 857
IT - Italia 444
HK - Hong Kong 440
RU - Federazione Russa 418
SE - Svezia 350
UA - Ucraina 320
VN - Vietnam 311
BR - Brasile 310
CA - Canada 296
IE - Irlanda 281
DE - Germania 237
GB - Regno Unito 157
IN - India 123
FR - Francia 115
FI - Finlandia 76
AT - Austria 66
KR - Corea 64
BD - Bangladesh 59
NL - Olanda 43
AR - Argentina 34
IQ - Iraq 33
ZA - Sudafrica 33
PK - Pakistan 32
MX - Messico 24
SA - Arabia Saudita 24
TR - Turchia 24
VE - Venezuela 21
CO - Colombia 20
ES - Italia 19
ID - Indonesia 19
EC - Ecuador 18
PH - Filippine 17
BE - Belgio 16
UZ - Uzbekistan 16
JP - Giappone 13
CL - Cile 11
CR - Costa Rica 11
MY - Malesia 10
PL - Polonia 10
CZ - Repubblica Ceca 8
EG - Egitto 8
NI - Nicaragua 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 6
JO - Giordania 6
LB - Libano 6
PE - Perù 6
SV - El Salvador 6
UY - Uruguay 6
AU - Australia 5
ET - Etiopia 5
HU - Ungheria 5
IL - Israele 5
IR - Iran 5
MA - Marocco 5
OM - Oman 5
PY - Paraguay 5
BO - Bolivia 4
HN - Honduras 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
LY - Libia 4
MN - Mongolia 4
PT - Portogallo 4
AL - Albania 3
BG - Bulgaria 3
CW - ???statistics.table.value.countryCode.CW??? 3
DZ - Algeria 3
EE - Estonia 3
EU - Europa 3
GP - Guadalupe 3
GT - Guatemala 3
JM - Giamaica 3
KG - Kirghizistan 3
NP - Nepal 3
AM - Armenia 2
AO - Angola 2
BS - Bahamas 2
DK - Danimarca 2
GE - Georgia 2
HR - Croazia 2
LK - Sri Lanka 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RO - Romania 2
SC - Seychelles 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BB - Barbados 1
BN - Brunei Darussalam 1
CM - Camerun 1
CY - Cipro 1
Totale 13.595
Città #
Ashburn 765
Woodbridge 664
Singapore 626
Ann Arbor 558
Hong Kong 433
Houston 360
Jacksonville 342
Chandler 329
Fairfield 298
San Jose 296
Dublin 270
Council Bluffs 202
Toronto 167
New York 155
Wilmington 148
Santa Clara 144
Milan 141
Frankfurt am Main 136
Princeton 123
Beijing 122
Dallas 119
Chicago 114
Seattle 108
Cambridge 98
Hefei 97
Dearborn 95
Ho Chi Minh City 92
Los Angeles 89
The Dalles 71
Nanjing 63
Seoul 62
Hanoi 61
Lawrence 59
Vienna 57
Altamura 55
Fuzhou 55
Lachine 55
Lauterbourg 51
Shanghai 51
Boardman 48
São Paulo 38
Rome 35
Buffalo 34
Munich 27
Nanchang 24
Moscow 23
Norcross 23
San Diego 22
Changsha 20
Guangzhou 20
London 20
Helsinki 19
Andover 17
Huizen 17
Jiaxing 17
Lahore 17
Mountain View 17
Falls Church 16
Montreal 16
Brooklyn 15
Dhaka 15
Tianjin 15
Zhengzhou 15
Denver 13
Haiphong 12
Johannesburg 12
Orem 12
Philadelphia 12
Shenyang 12
Tashkent 12
Atlanta 11
Da Nang 11
Hebei 11
Ottawa 11
Amsterdam 10
Brussels 10
Jeddah 10
Baghdad 9
Delhi 9
Figino 9
Jinan 9
Leawood 9
Ningbo 9
Norwalk 9
Phoenix 9
Tampa 9
Warsaw 9
Biên Hòa 8
Charlotte 8
Chennai 8
Guayaquil 8
Rio de Janeiro 8
San Francisco 8
Turin 8
Boston 7
Caracas 7
Managua 7
Memphis 7
Mumbai 7
Salt Lake City 7
Totale 8.608
Nome #
Near infrared spectroscopy (NIRS) as a new non-invasive tool to detect oxidative skeletal muscle impairment in children survived to acute lymphoblastic leukaemia 364
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 353
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 331
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia 314
Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children 311
Treatment of childhood acute lymphoblastic leukemia in central America: A lower-middle income countries experience 301
Screening for Coagulopathy and Identification of Children With Acute Lymphoblastic Leukemia at a Higher Risk of Symptomatic Venous Thrombosis: An AIEOP Experience 300
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia 289
The Controversy of Varicella Vaccination in Children With Acute Lymphoblastic Leukemia 278
Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow 273
Biochemical and genetic defects underlying human congenital hypotransferrinemia 261
A Childhood Leukaemia Cluster in Milan: Possible Role of Pandemic AH1N1 Swine Flu Virus 258
Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: A systematic review and meta-analysis 256
The eleventh international childhood acute lymphoblastic leukemia workshop report: Ponte di Legno, Italy, 6-7 may 2009 251
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy 250
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group 246
Possible role of pandemic AH1N1 swine flu virus in a childhood leukemia cluster 245
Non-conventional therapies in childhood cancer: guidelines for distinguishing non-harmful from harmful therapies: a report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology 241
Skeletal muscle impairment in children after treatment for leukemia. 238
Role of early diagnosis for a noninvasive treatment of pulmonary thromboembolism in leukemic children 237
The Role of Twinning Programs and Telemedicine in Pediatric Oncology 233
The eighth international childhood acute lymphoblastic leukemia workshop ('Ponte di Legno meeting') report: Vienna, Austria, April 27-28, 2005 229
Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation 229
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial 228
The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005 224
Periodic erythroexchange is an effective strategy for high risk paediatric patients with sickle-cell disease 224
Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies 224
Role of DNA index in childhood acute lymphoblastic leukemia treated with BFM based therapy: Long term results of the AIEOP-ALL 95 220
Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia 215
Improving outcomes for children with cancer in low-income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-part I 214
Degree in medicine: A model of teaching pediatrics in the classroom and in the field 214
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study 213
GH deficiency in adult B-thalassemia major patients and its relationship with IGF-1 production 212
A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup collaboration 210
Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop 208
Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective study 207
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia 206
Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible 206
High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo- tonsillitis: An epidemiological and molecular study 205
Income matters: reducing the mortality gap 203
Protocol-based treatment for children with cancer in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)--part II 202
Communicating with the dying child: An invitation to listening--a report of the SIOP working committee on psychosocial issues in pediatric oncology 201
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies 198
A formulary for pediatric oncology in developing countries 197
Purging iron from the heart 196
Clinical epidemiology of childhood cancer in Central America and Caribbean countries 194
Non-conventional therapies in childhood cancer: Guidelines for distinguishing non-harmful from harmful therapies: A report of the SIOP working committee on psychosocial issues in pediatric oncology 192
AMOR: a proposed cooperative effort to improve outcomes of childhood cancer in Central America 189
Long term survivors of childhood cancer: Cure and care The Erice Statement 187
Treatment of pediatric non-Hodgkin lymphomas in a country with limited resources: results of the first national protocol in Nicaragua 186
Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000) 185
Statement by members of the Ponte di Legno Group on the right of children to have full access to essential treatment for acute lymphoblastic leukemia 185
Development of lens opacities with peculiar characteristics in patients affected by thalassemia major on chelating treatment with deferasirox (ICL670) at the Pediatric Clinic in Monza, Italy 183
A survey of resources and activities in the MISPHO family of institutions in Latin America: a comparison of two eras 175
Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III 171
All children have a right to full access to treatment for cancer 163
Prenatal origin of acute lymphoblastic leukaemia in children 163
Road Traffic Pollution and Childhood Leukemia: A Nationwide Case-control Study in Italy 161
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood 159
Successful recovery of acute hemosiderotic heart failure in beta-thalassemia major treated with a combined regimen of desferrioxamine and deferiprone 144
Statement by members of the Ponte di Legno group on the right of children with leukemia to have full access to essential treatment for acute lymphoblastic leukemia 115
Totale 13.667
Categoria #
all - tutte 49.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022389 0 0 0 0 43 38 22 29 48 54 42 113
2022/20231.253 145 376 79 89 103 228 6 61 108 4 34 20
2023/2024744 26 20 28 24 113 215 147 20 56 6 6 83
2024/20251.670 111 248 79 71 169 36 64 82 147 233 151 279
2025/20264.214 327 274 342 355 516 231 562 237 429 458 200 283
2026/20271.390 57 143 393 687 110 0 0 0 0 0 0 0
Totale 13.667